EVALUATION OF THE GENOTOXICITY OF EURYCOMA LONGIFOLIA AQUEOUS EXTRACT (PHYSTA®) USING IN VITRO AMES TEST AND IN VIVO MAMMALIAN MICRONUCLEUS TEST

  • Yee K Ming Biotropics Malaysia, Division of Product Development Berhad, Lot 21 Jalan U1/19, Section U1, Hicom-Glenmarie Industrial Park, 0150 Shah Alam Selangor, Malaysia
  • Noraisyah Bt Zulkawi Biotropics Malaysia, Division of Product Development Berhad, Lot 21 Jalan U1/19, Section U1, Hicom-Glenmarie Industrial Park, 0150 Shah Alam Selangor, Malaysia
  • Vandana K Choudhary Biotropics Malaysia, Division of Product Development Berhad, Lot 21 Jalan U1/19, Section U1, Hicom-Glenmarie Industrial Park, 0150 Shah Alam Selangor, Malaysia
  • Yogendra K Choudhary Biotropics Malaysia, Division of Product Development Berhad, Lot 21 Jalan U1/19, Section U1, Hicom-Glenmarie Industrial Park, 0150 Shah Alam Selangor, Malaysia

Abstract

Objective: In this study the genotoxic potential of Eurycoma longifolia aqueous extract (PHYSTA®) was investigated by the in vitro Ames test (Salmonella/microsome mutation assay) and the in vivo mouse peripheral blood cell micronucleus test. Eurycoma longifolia also known as Tongkat Ali in Malaysia, is traditionally used in South East Asia to treat fever, intestinal worms, mouth ulcers, headache, erectile dysfunction and many other general pains. It is traditionally used as a health tonic and anti-stress remedy. Recent studies of Eurycoma longifolia pharmacological profile have revealed antioxidant properties and other potentially useful biological activities thereby lending some scientific support to its use in folk medicine. Evaluation of the genotoxic potential is one of the most important nonclinical safety studies required for registration and approval for marketing of pharmaceutical products.

Methods: The Salmonella/microsome mutation assay (TA 98, TA 100, TA 102, TA 1535 and TA 1537; plate incorporation method) was performed in the presence or in the absence of extrinsic metabolic activation (S9 mixture). In the mouse micronucleus assay, Eurycoma longifolia aqueous extract was administered intraperitoneally (100, 250 and 500 mg/kg body weight; single dose) to male and female NMRI mice (N= 5 per dose per sex) and peripheral blood was analyzed after 44 and 68 h after treatment using a flow cytometer to determine micro nucleated polychromatic (immature) erythrocytes.

Results: The results were expressed as the relative proportion of polychromatic erythrocytes among total erythrocytes (relative PCE). Tested at doses up to 5 mg/plate, the Eurycoma longifolia aqueous extract (PHYSTA®) was not toxic to Salmonella tester strains and did not increase the number of revertant colonies over the background incidence. In the mouse peripheral blood cell micronucleus assay, the extract did not alter the relative PCE, nor did it increase the incidence of micro nucleated polychromatic erythrocytes.

Conclusion: Based on the aforementioned findings, it is concluded that the Eurycoma longifolia aqueous extract (PHYSTA®) has no mutagenic potential and considered to be non-genotoxic with respect to clastogenicity.

 

Keywords: Eurycoma longifolia, Ames test, Micronucleus assay, Genotoxicity

Downloads

Download data is not yet available.

References

1. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003;52:1361–71.
2. Jamia AJ. Malay traditional medicine. An overview of scientific and technology advancement. Asia Pacific Tech Monitor 2006;23:37–49.
3. Kardono LBS, Angerhofer CK, Tsauri S, Padmawinata K, Pezzuto JM, Kinghorn AD. Cytotoxic and anti-malarial constituents of the roots of Eurycoma longifolia. J Nat Prod 1991;54:1360-7.
4. Ang HH, Hitotsuyanagi Y, Fukaya H, Takeya K. Quassinoids from Eurycoma longifolia. Phytochem 2002;59(8):833-7.
5. Ismail SB. Randomized clinical trial on the use of PHYSTA freeze-dried water extract of Eurycoma longifolia for the Improvement of quality of life and sexual well-being in men. Evidence-Based Complementary Altern Med 2012. doi.org/10.1155/2012/429268 [Article in Press]
6. Tambi MI. Eurycoma longifolia jack: a potent adaptogen in the form of water-soluble extract with the effects of maintaining men’s health. Asian J Androl 2006;8 Suppl 1:49-50.
7. Satyavivad J, Noppamas S, Aimon S, Yodhathai T. Toxicological and antimalarial activity of eurycomalactone and Eurycoma longifolia Jack extracts in mice. Thai J Phytopharm 1998;5:14-27.
8. Choudhary YK, Bommu P, Ming YK, Zulkawi N. Acute, sub acute and subchronic 90-days toxicity of Eurycoma longifolia aqueous extract (Physta®) in wistar rats. Int J Pharm Pharm Sci 2012;4:232-8.
9. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998;104:170–8.
10. Lewis DF, Loannide C, Parke DV. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U. S. NCI/NTP. Mutat Res 1993;291:61‐77.
11. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194–210.
12. Sugimura T. Nutrition and dietary carcinogens. Carcinogenesis 2000;21:387‐95.
13. Mohd‐Fuat AR, Kofi EA, Candlish AGG. Mutagenic and cytotoxic properties of three herbal plants from Southeast Asia. Trop Biomed 2007;24:49‐59.
Statistics
233 Views | 470 Downloads
How to Cite
Ming, Y. K., N. B. Zulkawi, V. K. Choudhary, and Y. K. Choudhary. “EVALUATION OF THE GENOTOXICITY OF EURYCOMA LONGIFOLIA AQUEOUS EXTRACT (PHYSTA®) USING IN VITRO AMES TEST AND IN VIVO MAMMALIAN MICRONUCLEUS TEST”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 8, 1, pp. 367-71, https://innovareacademics.in/journals/index.php/ijpps/article/view/8189.
Section
Original Article(s)